Table 2c.
BBB MODEL | CONDITION | Donor 1 | Donor 2 | Donor 3 | Donor 4 | Donor 5 | p-value* |
---|---|---|---|---|---|---|---|
INPUT | 25.8 | 24.4 | 38.0 | 28.2 | 27.9 | n/a | |
Basal IVBBB | No Chemokine-Non-migrated | 25.9 | 24.8 | 37.9 | 27.4 | 22.2 | n.s. |
Basal IVBBB | No Chemokine-Migrated | 23.1 | 26.6 | 41.1 | 27.8 | 27.5 | n.s. |
Basal IVBBB | + CCL5-Non-migrated | 24.7 | 22.4 | 36.6 | 31.2 | 24.6 | n.s. |
Basal IVBBB | + CCL5-Migrated | 16.4 | 15.6 | 27.4 | 21.9 | 19.9 | 0.03 |
aIVBBB | No Chemokine-Non-migrated | 24.4 | 22.4 | 39.3 | 27.2 | 27.1 | n.s. |
aIVBBB | No Chemokine-Migrated | 20.8 | 17.0 | 43.3 | 26.4 | 29.8 | n.s. |
aIVBBB | + CCL5-Non-migrated | 23.8 | 22.3 | 38.5 | 29.8 | 31.1 | n.s. |
aIVBBB | + CCL5-Migrated | 15.1 | 15.9 | 26.9 | 19.4 | 18.8 | 0.02 |
indicates that p-values were ascertained relative to the input MFI. Key: aIVBBB: cytokine-activated in vitro blood-brain barrier, IVBBB: in vitro blood-brain barrier, n/a: not applicable, n.s.: not significant.